COMBINATION THERAPY USING INTERFERON-.beta. AND INTERLEUKIN-2
CA 1291706 C · Owner: Rudolph, Alfred · Inventors: Rudolph, Alfred
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Anti-tumor activity in humans can be augmented by administering to the human patient an effective amount of IFN-.beta. and IL-2 in combination. The composition of IFN-.beta. and IL-2 may be prepared in vitro or administered separately to the patient. The composition is useful for prophylactic or therapeutic treatment of such cancers as melanoma, colon cancer lung cancer and breast cancer.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted November 5, 1991. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended November 5, 2008.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.